FTC looks into ads for genetic tests

Share this article:
The Federal Trade Commission has opened an investigation into the possible deceptive advertising and marketing of DTC genetic tests, according to The New York Times, which cited an FTC official speaking at a June 12 meeting convened by Sen. Gordon Smith (R-OR). 

Earlier in June, the AMA's House of Delegates adopted a resolution calling for more regulation of advertising by the industry, while California sent cease and desist letters to 13 companies that offer consumer genetic tests, demanding they stop testing until they can prove that their labs are licensed and that the tests were ordered by physicians, not patients. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?